Showing results (141-150 of 159) with videos related to
Sort By:
Pageof 16
Brain Connectivity|July 2, 2021
Structural Connectivity Patterns of Side Effects Induced by Subthalamic Deep Brain Stimulation for Parkinson's DiseaseQuirin D Strotzer, Zacharias Kohl, Judith M Anthofer, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2008
Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogsHandan He, Phi Tran, Hequn Yin, et al.Journal of Clinical Medicine|February 11, 2021
A Novel Language Paradigm for Intraoperative Language Mapping: Feasibility and EvaluationKatharina Rosengarth, Delin Pai, Frank Dodoo-Schittko, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 15, 2016
Metabolism and Disposition of Hepatitis C Polymerase Inhibitor Dasabuvir in HumansJianwei Shen, Michael Serby, Aimee Reed, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 15, 2016
Metabolism and Disposition of the Hepatitis C Protease Inhibitor Paritaprevir in HumansJianwei Shen, Michael Serby, Aimee Reed, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2018
Mathematical and Experimental Validation of Flux Dialysis Method: An Improved Approach to Measure Unbound Fraction for Compounds with High Protein Binding and Other Challenging PropertiesJ Cory Kalvass, Colin Phipps, Gary J Jenkins, et al.Plos One|February 18, 2011
Comprehensive small animal imaging strategies on a clinical 3 T dedicated head MR-scanner; adapted methods and sequence protocols in CNS pathologiesDeepu R Pillai, Robin M Heidemann, Praveen Kumar, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 10, 2017
Mechanisms and Predictions of Drug-Drug Interactions of the Hepatitis C Virus Three Direct-Acting Antiviral Regimen: Paritaprevir/Ritonavir, Ombitasvir, and DasabuvirMohamad Shebley, Jinrong Liu, Olga Kavetskaia, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2008
Absorption, metabolism, and excretion of [14C]vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in humansHandan He, Phi Tran, Hequn Yin, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 15, 2016
Metabolism and Disposition of Pan-Genotypic Inhibitor of Hepatitis C Virus NS5A Ombitasvir in HumansJianwei Shen, Michael Serby, Bruce Surber, et al.Pageof 16